(R)-TETRAHYDRO-3H-PYRROLO[1,2-C][1,2,3]OXATHIAZOLE 1,1-DIOXIDE, 95.0%, 250mg

[3-(2H-tetrazol-2-yl)-1-adamantyl]amine hydrochloride hydrate, 95.0%, 10g

Ethyl 2-amino-2-iminoacetate hydrochloride, 95.0%, 1g

5-(Hydroxymethyl)isoxazole-3-carboxylic acid, 95.0%, 500mg

4,4,5,5-Tetramethyl-2-(2,3,4-trifluorophenyl)-1,3,2-dioxaborolane, 97%, 5g

5-Bromo-1,2,3,6-tetrahydro-pyridine hydrochloride, 96%, 500mg

2-(((Benzyloxy)carbonyl)amino)-3-(1H-indol-3-yl)propanoic acid, 95.0%, 500g

TERT-BUTYL (4-BENZYLMORPHOLIN-2-YL)METHYLCARBAMATE, 95.0%, 5g

Ethyl 1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl)piperidine-3-carboxylate, 95.0%, 250mg

Minicentrífuga serie EBA, EBA 200 S, 6153 xg, 8000 min¹, 1 pieza

4-(Furan-2-ylmethyl)thiomorpholine 1,1-dioxide, 98%, 5g

3-(Benzyloxy)-6-bromo-4-methoxypicolinic acid, 95+%, 1g

Tiagabine Hydrochloride>99.0%(HPLC)250mg